Skip to main content

Table 2 Pre-dose morning PEF (L/min) - Change from baseline to the entire treatment period

From: High strength extrafine pMDI beclometasone/formoterol (200/6 μg) is effective in asthma patients not adequately controlled on medium-high dose of inhaled corticosteroids

ITT population

 

BDP/FF

N = 184

BDP

N = 175

Change from baseline to the entire treatment period

n

182

170

Adjusted mean (95% CI)

17.63 (11.58, 23.68)

-0.90 (-7.26, 5.46)

Adjusted mean difference BDP/FF vs. BDP (95% CI), p-value

18.53 (10.33, 26.73), < 0.001

PP population

 

BDP/FF

N = 176

BDP

N = 164

Change from baseline to the entire treatment period

n

176

163

Adjusted mean (95% CI)

17.85 (11.60, 24.10),

-0.21 (-6.76, 6.35)

Adjusted mean difference BDP/FF vs. BDP (95% CI), p-value

18.06 (9.63, 26.49), < 0.001